Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FVLJ1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,533
Award facts
- Contract value 100% obligated
- $18,533.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has received a delivery order valued at $18,533.21 from the Defense Logistics Agency (DLA) for Aimovig 140 mg/ml auto-injectors. The award, issued on September 15, 2025, represents a firm fixed price contract with an ultimate completion date of September 16, 2025. This is a competitively awarded, non-set-aside delivery order falling under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Aimovig, a monoclonal antibody used to treat migraine headaches, represents one of the specialized medications within AmerisourceBergen's extensive portfolio of federal medical supplies. The delivery order demonstrates the company's role as a critical vendor for the Defense Health Agency and broader military healthcare systems, supplying both brand-name specialty pharmaceuticals and conventional medical commodities. As a child contract under the SPE2DX prime vehicle, this award exemplifies the operational flexibility of DLA's pharmaceutical procurement strategy and AmerisourceBergen's established capability to fulfill federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FVLJ1?
SPE2DB25FVLJ1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FVLJ1 worth?
The government has obligated $18,533 on SPE2DB25FVLJ1.
Is contract SPE2DB25FVLJ1 an order under another contract?
Yes. SPE2DB25FVLJ1 is a delivery order under SPE2DB22D1202, an indefinite delivery contract.
Was contract SPE2DB25FVLJ1 competed?
The extent of competition for SPE2DB25FVLJ1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award